Cargando…
Molecular Signature of Small Cell Lung Cancer after Treatment Failure: The MCM Complex as Therapeutic Target
SIMPLE SUMMARY: Small cell lung cancer (SCLC) is a fatal malignant tumor with a poor prognosis for patients who relapse after first-line treatment. There are few effective treatments for SCLC patients with relapse. Elucidation of the molecular network related to treatment resistance is an important...
Autores principales: | Misono, Shunsuke, Mizuno, Keiko, Suetsugu, Takayuki, Tanigawa, Kengo, Nohata, Nijiro, Uchida, Akifumi, Sanada, Hiroki, Okada, Reona, Moriya, Shogo, Inoue, Hiromasa, Seki, Naohiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998124/ https://www.ncbi.nlm.nih.gov/pubmed/33801812 http://dx.doi.org/10.3390/cancers13061187 |
Ejemplares similares
-
FAM64A: A Novel Oncogenic Target of Lung Adenocarcinoma Regulated by Both Strands of miR-99a (miR-99a-5p and miR-99a-3p)
por: Mizuno, Keiko, et al.
Publicado: (2020) -
Regulation of Oncogenic Targets by Tumor-Suppressive miR-150-3p in Lung Squamous Cell Carcinoma
por: Mizuno, Keiko, et al.
Publicado: (2021) -
MicroRNA signature of small‐cell lung cancer after treatment failure: impact on oncogenic targets by miR‐30a‐3p control
por: Tanigawa, Kengo, et al.
Publicado: (2022) -
Molecular Pathogenesis of Gene Regulation by the miR-150 Duplex: miR-150-3p Regulates TNS4 in Lung Adenocarcinoma
por: Misono, Shunsuke, et al.
Publicado: (2019) -
Involvement of Dual Strands of miR-143 (miR-143-5p and miR-143-3p) and Their Target Oncogenes in the Molecular Pathogenesis of Lung Adenocarcinoma
por: Sanada, Hiroki, et al.
Publicado: (2019)